Fumaric Acid

Fumaric Acid

SCHEMBL8015995

CS(=O)(=O)NCCN1CCC(CN(C(=O)O)c2ccccc2-c2nc(-c3ccccc3)no2)CC1.O=C(O)C=CC(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 known ✓ Q13639 4/20 0.37
KCNH2 known ✓ Q12809 2/20 0.37
S1PR1 known ✓ P21453 2/20 0.36
MAPT P10636 1/20 0.39
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
PMP22 Q01453 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CHRNA7 P36544 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
KDM1A O60341 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL8015989 1.00 MAPT (0.39) MAPTHTR4CYP1A2CYP2C9ALOX15
SCHEMBL7402277 0.96 MAPT (0.42) MAPTHTR4CYP1A2CYP2C9ALOX15
Fumaric Acid SCHEMBL7401482 0.90 HTR4 (0.37) HTR4CYP1A2CYP2C9ALOX15NFKB1
Maleic Acid SCHEMBL7401474 0.90 HTR4 (0.37) HTR4CYP1A2CYP2C9ALOX15NFKB1
Fumaric Acid SCHEMBL8133485 0.90 KDM1A (0.37) MAPTHTR4CYP1A2CYP2C9ALOX15
Maleic Acid SCHEMBL8133481 0.90 KDM1A (0.37) MAPTHTR4CYP1A2CYP2C9ALOX15
SCHEMBL8015991 0.89 HTR4 (0.38) MAPTHTR4CYP1A2CYP2C9ALOX15
SCHEMBL1039396 0.87 HTR4 (0.40) HTR4CYP1A2CYP2C9ALOX15NFKB1
Maleic Acid SCHEMBL7398825 0.87 SMN1; SMN2 (0.35) MAPTHTR4CYP1A2CYP2C9ALOX15
Fumaric Acid SCHEMBL7398829 0.87 SMN1; SMN2 (0.35) MAPTHTR4CYP1A2CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0972773-A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates GLAXO GROUP LIMITED (GB) 2000-01-19 EP disclosed
EP-0640081-B1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT4 ANTAGONISTS GLAXO GROUP LTD (GB) 2000-01-12 EP disclosed
US-5618827-A TREATING GASTROINTESTINAL, URINARY, CARDIOVASCULAR, CENTRAL NERVOUS SYTEM DISORDERS GLAXO GROUP LIMITED (GB) 1997-04-08 US disclosed